Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH)
|
Add to portfolio |
|
|
|
| Price: |
$3.01
| | Metrics |
| OS: |
22.7
|
M
| |
|
|
| Market cap: |
$68.2
|
M
| |
|
|
|
Net cash:
|
$10.9
|
M
| |
$0.48
|
per share
|
|
EV:
|
$57.2
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($10.4)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 0.0 | 0.0 | 0.0 |
| Cost of goods sold | 0.0 | 0.0 | 0.0 |
| Gross profit | 0.0 | 0.0 | 0.0 |
| Selling, general and administrative | 0.0 | | |
| Research and development | | 0.3 | 0.2 |
| General and administrative | 0.0 | 2.1 | 0.2 |
| EBIT | 0.0 | -2.4 | -0.4 |
| Pre-tax income | -8.5 | -3.8 | -0.8 |
| Income taxes | 0.0 | 0.0 | 0.0 |
| Net income | -8.5 | -3.8 | -0.8 |
| |
| Diluted EPS | | ($1.24) | ($0.31) |
| Shares outstanding (diluted) | | 3.1 | 2.8 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|